Triple-negative breast cancer: Novel therapies and new directions
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- The epidemiology of triple-negative breast cancer, including raceCancer Causes & Control, 2009
- Triple-negative breast cancers are increased in black women regardless of age or body mass indexBreast Cancer Research, 2009
- High prevalence of triple‐negative tumors in an urban cancer centerCancer, 2008
- Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GABreast Cancer Research and Treatment, 2008
- Triple-Negative Breast Cancer: Clinical Features and Patterns of RecurrenceClinical Cancer Research, 2007
- Lapatinib plus Capecitabine for HER2-Positive Advanced Breast CancerNew England Journal of Medicine, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Aromatase Inhibitors in Breast CancerNew England Journal of Medicine, 2003
- Selective Estrogen-Receptor Modulators — Mechanisms of Action and Application to Clinical PracticeNew England Journal of Medicine, 2003
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine, 2001